Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025
Bristol Myers Squibb (NYSE: BMY) has scheduled its first quarter 2025 financial results announcement for Thursday, April 24, 2025. The company will host a conference call and webcast at 8:00 a.m. ET where executives will discuss the quarterly results with the investment community.
Investors and the public can access the live webcast through the company's investor relations website at http://investor.bms.com. Related materials will be available on the same platform before the call begins. A replay of the webcast will be accessible approximately three hours after the conference call ends.
Bristol Myers Squibb (NYSE: BMY) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 24 aprile 2025. L'azienda ospiterà una conferenza telefonica e un webcast alle 8:00 a.m. ET in cui i dirigenti discuteranno i risultati trimestrali con la comunità degli investitori.
Gli investitori e il pubblico possono accedere al webcast dal vivo tramite il sito web delle relazioni con gli investitori dell'azienda all'indirizzo http://investor.bms.com. Materiale correlato sarà disponibile sulla stessa piattaforma prima dell'inizio della chiamata. Una registrazione del webcast sarà accessibile circa tre ore dopo la conclusione della conferenza telefonica.
Bristol Myers Squibb (NYSE: BMY) ha programado el anuncio de los resultados financieros del primer trimestre de 2025 para jueves 24 de abril de 2025. La compañía llevará a cabo una conferencia telefónica y un webcast a las 8:00 a.m. ET donde los ejecutivos discutirán los resultados trimestrales con la comunidad inversora.
Los inversores y el público pueden acceder al webcast en vivo a través del sitio web de relaciones con inversores de la compañía en http://investor.bms.com. Material relacionado estará disponible en la misma plataforma antes de que comience la llamada. Una repetición del webcast estará accesible aproximadamente tres horas después de que finalice la conferencia telefónica.
Bristol Myers Squibb (NYSE: BMY)는 2025년 4월 24일 목요일에 2025년 1분기 재무 결과 발표를 예정하고 있습니다. 회사는 오전 8시 ET에 컨퍼런스 콜과 웹캐스트를 개최하여 경영진이 투자자 커뮤니티와 분기 결과를 논의할 것입니다.
투자자와 대중은 회사의 투자자 관계 웹사이트 http://investor.bms.com를 통해 실시간 웹캐스트에 접근할 수 있습니다. 관련 자료는 전화 회의 시작 전에 동일한 플랫폼에서 제공될 것입니다. 웹캐스트의 재생은 전화 회의 종료 후 약 3시간 후에 접근할 수 있습니다.
Bristol Myers Squibb (NYSE: BMY) a programmé l'annonce de ses résultats financiers pour le premier trimestre 2025 pour jeudi 24 avril 2025. L'entreprise organisera une conférence téléphonique et un webinaire à 8h00 ET où les dirigeants discuteront des résultats trimestriels avec la communauté des investisseurs.
Les investisseurs et le public peuvent accéder au webinaire en direct via le site web des relations investisseurs de l'entreprise à l'adresse http://investor.bms.com. Les documents connexes seront disponibles sur la même plateforme avant le début de l'appel. Un replay du webinaire sera accessible environ trois heures après la fin de la conférence téléphonique.
Bristol Myers Squibb (NYSE: BMY) hat die Bekanntgabe der finanziellen Ergebnisse für das erste Quartal 2025 auf Donnerstag, den 24. April 2025 festgelegt. Das Unternehmen wird um 8:00 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, in dem die Führungskräfte die Quartalsergebnisse mit der Investmentgemeinschaft besprechen werden.
Investoren und die Öffentlichkeit können den Live-Webcast über die Investor-Relations-Website des Unternehmens unter http://investor.bms.com abrufen. Verwandte Materialien werden vor Beginn des Anrufs auf derselben Plattform verfügbar sein. Eine Wiederholung des Webcasts wird etwa drei Stunden nach Ende der Telefonkonferenz zugänglich sein.
- None.
- None.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313006466/en/
Media Relations:
media@bms.com
Investor Relations:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
When will Bristol Myers Squibb (BMY) release Q1 2025 earnings?
What time is BMY's Q1 2025 earnings conference call?
How can investors access BMY's Q1 2025 earnings call?
When will BMY's Q1 2025 earnings call replay be available?
